Has Mark Gardner, DO received payments from drug or device companies?

Yes. Drug and device makers reported $18,763 in general payments to Mark Gardner, DO across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Gardner, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Gardner, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Gardner, DO

Orthopaedic Surgery · Hermitage, PANPI 1467766022

Payments from drug & device makers

$18,763in general payments, 2019–2025

Across 131 payments — averaging $143.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$10K
Smith+Nephew$3K
Stryker$3K
Mid-atlantic Surgical Systems, LLC$3K
Bioventus LLC$87

What the payments were for

Travel & lodging$10,11454%
Food & beverage$4,93626%
Education$3,71320%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	66	$10,141
Smith+Nephew	17	$3,097
Stryker	37	$2,932
Mid-atlantic Surgical Systems, LLC	10	$2,507
Bioventus LLC	1	$87

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,763 in reported general payments places this provider in the 75th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$355,035

Medicare patients

562

Services billed

2,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	248	$761
Diclofenac Sodium	34	$461
Methylprednisolone	79	$334
Celecoxib	11	$222
Naproxen	14	$145
Tramadol Hcl	45	$135
Amoxicillin	166	$123
Mupirocin	20	$104
Clindamycin Hcl	44	$46
Gabapentin	11	$42
Cyclobenzaprine Hcl	15	$39

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Hermitage

William HozackBensalem$10.6M
Jess LonnerBryn Mawr$8.1M
Gerald WilliamsBryn Mawr$6.8M
Mark LazarusBensalem$6.4M
John FenlinPhiladelphia$5.9M
Peter SharkeyKing Of Prussia$5.7M
Selene ParekhBensalem$4.9M
Alexander VaccaroPhiladelphia$4.5M
Joseph AbboudPhiladelphia$4.1M
Jonathan GarinoMalvern$3.8M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →